The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical utilization of Breast Cancer Index (BCI) for late recurrence risk assessment and prediction of extended endocrine therapy (EET) benefit in early stage HR+ breast cancer.
 
Reshma L. Mahtani
Consulting or Advisory Role - Amgen; bioTheranostics; Celgene; Genentech; Pfizer; Sandoz
Research Funding - Genentech (Inst)
Travel, Accommodations, Expenses - Amgen; bioTheranostics; Celgene; Genentech/Roche; Pfizer
 
Vijayakrishna K. Gadi
Stock and Other Ownership Interests - Sengine precision medicine
Research Funding - Genentech (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - PNP Therapeutics
 
Theresa N. Operana
Employment - bioTheranostics
Stock and Other Ownership Interests - bioTheranostics
 
Harris S Soifer
Employment - bioTheranostics
Stock and Other Ownership Interests - bioTheranostics
 
Brock Schroeder
Employment - bioTheranostics
Stock and Other Ownership Interests - bioTheranostics
 
Catherine A. Schnabel
Employment - Biotheranostics
Leadership - Biotheranostics
Stock and Other Ownership Interests - Biotheranostics
 
Lee Steven Schwartzberg
Honoraria - Amgen; Bristol-Myers Squibb; Pfizer; Tesaro
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Helsinn Therapeutics; Pfizer
Speakers' Bureau - Genentech/Roche
Research Funding - Helsinn Therapeutics